Cargando…

Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: A Swedish observational study

OBJECTIVE: Low-level viraemia (LLV) occurs in some people with HIV (PWH) receiving antiretroviral therapy (ART) and has been linked to inferior treatment outcomes. We investigated factors associated with LLV in a nationwide cohort of Swedish PWH starting ART. METHODS: Participants were identified fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brattgård, Hanna, Björkman, Per, Nowak, Piotr, Treutiger, Carl Johan, Gisslén, Magnus, Elvstam, Olof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113572/ https://www.ncbi.nlm.nih.gov/pubmed/35580115 http://dx.doi.org/10.1371/journal.pone.0268540

Ejemplares similares

All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study
por: Elvstam, Olof, et al.
Publicado: (2020)

Associations Between Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid Levels and Incidence of Invasive Cancer in People With HIV After Initiation of Combination Antiretroviral Therapy
por: Elvstam, Olof, et al.
Publicado: (2021)

Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
por: Elvstam, Olof, et al.
Publicado: (2017)

Higher plasma drug levels in elderly people living with HIV treated with darunavir
por: Tyrberg, Erika, et al.
Publicado: (2021)

The Swedish COVID-19 approach: a scientific dialogue on mitigation policies
por: Björkman, Anders, et al.
Publicado: (2023)

Cardiovascular Profile of South African Adults with Low-Level Viremia during Antiretroviral Therapy
por: Botha-Le Roux, Shani, et al.
Publicado: (2022)

Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort
por: Elvstam, Olof, et al.
Publicado: (2022)

Pleural effusion disease in rabbits: Observations on viraemia, immunity and transmissibility
por: Fennestad, K. L., et al.
Publicado: (1981)

Patterns of detectable viraemia among children and adults with HIV infection taking antiretroviral therapy in Zimbabwe
por: Sovershaeva, Evgeniya, et al.
Publicado: (2019)

HIV: how to manage low-level viraemia in people living with HIV
por: Hanners, Emily K, et al.
Publicado: (2022)

The association between low-level viraemia and subsequent viral non-suppression among people living with HIV/AIDS on antiretroviral therapy in Uganda
por: Nanyeenya, Nicholus, et al.
Publicado: (2023)

Short- and Long-Term Mortality in Severe Sepsis/Septic Shock in a Setting with Low Antibiotic Resistance: A Prospective Observational Study in a Swedish University Hospital
por: Linnér, Anna, et al.
Publicado: (2013)

The molecular epidemiology of HIV-1 in Sweden 1996 to 2022, and the influence of migration from Ukraine
por: Weibull Wärnberg, Anna, et al.
Publicado: (2023)

Cohort profile: InfCareHIV, a prospective registry-based cohort study of people with diagnosed HIV in Sweden
por: Carlander, Christina, et al.
Publicado: (2023)

Hopes, joys and fears: Meaning and perceptions of viral load testing and low-level viraemia among people on antiretroviral therapy in Uganda: A qualitative study
por: Nanyeenya, Nicholus, et al.
Publicado: (2023)

HIV viraemia during pregnancy in women receiving preconception antiretroviral therapy in KwaDukuza, KwaZulu-Natal
por: Ntlantsana, Vuyokazi, et al.
Publicado: (2019)

Comparison of cumulative viraemia following treatment initiation with different antiretroviral regimens: a real‐life study in Brazil
por: Pascom, Ana R, et al.
Publicado: (2019)

Risk factors, mortality trends and cardiovasuclar diseases in people with Type 1 diabetes and controls: A Swedish observational cohort study
por: Hallström, Sara, et al.
Publicado: (2022)

Control of HIV viraemia is not enough in perinatal HIV
por: Foster, Caroline, et al.
Publicado: (2015)

Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/r Based Antiretroviral Therapy
por: Vesterbacka, Jan, et al.
Publicado: (2013)

Diagnostic accuracy of a point‐of‐care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz‐based antiretroviral therapy
por: Dorward, Jienchi, et al.
Publicado: (2023)

Intermittent viraemia and immune reconstitution in patients with more than 10–15 years of antiretroviral therapy: baseline values still matter
por: Erdbeer, Gesa, et al.
Publicado: (2014)

JC viraemia in kidney transplant recipients: to act or not to act?
por: Rao, N., et al.
Publicado: (2012)

Steroid harms if given early in COVID-19 viraemia
por: Arora, Kanupriya, et al.
Publicado: (2021)

Low-level viraemia among people living with HIV in Nigeria: a retrospective longitudinal cohort study
por: Chun, Helen M, et al.
Publicado: (2022)

Prediction of early race starts in Norwegian-Swedish Coldblooded Trotters
por: Revold, Tobias, et al.
Publicado: (2010)

Recovery of effective HIV-specific CD4(+) T-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia
por: Adland, Emily, et al.
Publicado: (2018)

The Impact of Low-Level Viraemia on Virological Failure—Results From a Multicenter HIV Antiretroviral Therapy Cohort Study in Yunnan, China
por: An, Jing, et al.
Publicado: (2022)

Low-level viraemia despite emergence of dolutegravir-resistant variants
por: Botha, Johannes C., et al.
Publicado: (2022)

Low-level viraemia: An emerging concern among people living with HIV in Uganda and across sub-Saharan Africa
por: Nanyeenya, Nicholus, et al.
Publicado: (2022)

A retrospective observational study of low-level viraemia and its immunological and virological significance: which outcome to expect
por: Silva, Joana, et al.
Publicado: (2014)

When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010)

Immediate start of antiretroviral, why not?
por: Matsuda, Elaine Monteiro, et al.
Publicado: (2018)

Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
por: Albert, Jan, et al.
Publicado: (2014)

Swedish Covid-19 Investigation for Future Insights – A Population Epidemiology Approach Using Register Linkage (SCIFI-PEARL)
por: Nyberg, Fredrik, et al.
Publicado: (2021)

HIV-2 gene product-specific T cell responses and viraemia control
por: Leligdowicz, Aleksandra, et al.
Publicado: (2006)

Low level viraemia and the risk of virological failure in HIV infected patients
por: Florea, Dragoş, et al.
Publicado: (2014)

BTV-14 Infection in Sheep Elicits Viraemia with Mild Clinical Symptoms
por: Flannery, John, et al.
Publicado: (2020)

Evaluation on the antiviral activity of arctigenin against spring viraemia of carp virus
por: Shen, Yu-Feng, et al.
Publicado: (2018)

Incidence of Severe Neutropenia in HIV-Infected People Starting Antiretroviral Therapy in West Africa
por: Leroi, Charline, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ikjqjh6r9b8gbhjlc4muu6iihd